Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods§

Authors


  • The maps in Figure 5 were developed by James Cucinelli (IMS, Inc.) and Dave Stinchcomb (National Cancer Institute) based on the micromaps design (Carr and Pierson, 1996). Fonda Martin provided additional graphics assistance.

  • The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

  • §

    This is a US government work and, as such, is in the public domain in the United States of America.

Abstract

Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV-associated cancers. This article describes methods used to assess the burden of HPV-associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers. Cancer 2008;113(10 suppl):2841–54. Published 2008 by the American Cancer Society.

Ancillary